4.5 Article

Impact of adverse pancreatic injury at surgical procurement upon islet isolation outcome

Journal

TRANSPLANT INTERNATIONAL
Volume 27, Issue 11, Pages 1135-1142

Publisher

WILEY-BLACKWELL
DOI: 10.1111/tri.12392

Keywords

donor; islet transplantation; organ procurement; pancreas

Funding

  1. Alberta Innovates [201201154] Funding Source: researchfish

Ask authors/readers for more resources

The consequence of a pancreas injury during the procurement for islet isolation purpose is unknown. The goal of this work was to assess the injuries of the pancreata procured for islet isolation, and to determine their effect on the islet yield. Between January 2007 and October 2013, we prospectively documented every injury of the pancreata processed in our centre for islet isolation. Injuries involving the main duct were classified as major, the others as minor. Donors' characteristics and islet yields were compared between the groups of injuries. A pancreas injury was identified in 42 of 452 pancreata received for islet isolation (9.3%). In 15 cases, the injury was major (3.3% of all pancreata). Although a minor injury did not affect the islet yield, a major injury was significantly associated with unfavourable outcomes (postpurification mean islet equivalent of 364 +/- 181, 405 +/- 190 and 230 +/- 115x10(3) for absence of injury, minor injury and major injury, respectively). A major injury was significantly more prevalent in lean and short donors. We recommend assessing the quality of the pancreas in the islet isolation centre before starting the isolation procedure. Each centre should determine its own policy based on its financial resources and on the wait list.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Transplantation

Serum testosterone concentrations and outcomes in hemodialysis patients enrolled in the EVOLVE trial

Erik Nilsson, Peter Stenvinkel, Sai Liu, Margaret R. Stedman, Glenn M. Chertow, Juergen Floege

Summary: Lower free testosterone and higher SHBG in serum are associated with higher risk of death or cardiovascular event in men undergoing chronic hemodialysis.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Pediatrics

Cystic Fibrosis-Related Diabetes: Clinical approach and knowledge gaps

Bernadette J. Prentice, Kathryn J. Potter, Adele Coriati, Valerie Boudreau, Leah Rusnell, Tamizan Kherani, A. Peter, Shihab Hameed, Remi Rabasa-Lhoret

Summary: Cystic Fibrosis-Related Diabetes (CFRD) is a distinct type of diabetes that combines features of both type 1 and type 2 diabetes. However, its characteristic acute pulmonary complications and catabolic metabolism pose challenges to traditional definitions and treatments for diabetes. Patients with CF undergo annual screening from the age of 10, which is hindered by limited accuracy and reproducibility. As the lifespan of CF patients increases, over 50% are expected to develop CFRD, including a significant proportion of adolescents. Evidence-based practice in CFRD is currently limited due to small and short-term studies, but recent advancements in CFTR modulator medications may change our understanding. This review discusses the challenges in diagnosing and managing CFRD, highlighting knowledge gaps, screening methods, research priorities, and providing guidance for screening, diagnosis, and treatment.

PAEDIATRIC RESPIRATORY REVIEWS (2023)

Article Immunology

C-peptide Targets and Patient-centered Outcomes of Relevance to Cellular Transplantation for Diabetes

Kevin Verhoeff, Braulio A. Marfil-Garza, Khaled Dajani, David L. Bigam, Blaire Anderson, Tatsuya Kin, Anna Lam, Doug O'Gorman, Peter A. Senior, A. M. James Shapiro

Summary: This study analyzed patients undergoing islet transplantation and found that C-peptide levels are correlated with blood glucose control and insulin independence. The study determined threshold values for insulin independence and hypoglycemic freedom based on C-peptide levels, as well as BETA-2 scores, providing reference values for evaluating pancreatic or stem cell therapies.

TRANSPLANTATION (2023)

Article Endocrinology & Metabolism

Use of Classes of Antihyperglycemic Agents in People With Type 2 Diabetes Based on Level of Estimated Glomerular Filtration Rate

Jeremy Gilbert, Phil McFarlane, James Kim, Susie Jin, Peter Senior, Jeremy Gilbert, Harpreet S. Bajaj, Susie Jin, James Kim, Harpreet S. Bajaj, Jeremy Gilbert, Robyn Houlden, James Kim, Barbara MacDonald, Dylan MacKay, Kerry Mansell, Doreen Rabi, Diana Sherifali, Peter Senior

CANADIAN JOURNAL OF DIABETES (2023)

Article Nutrition & Dietetics

Phosphorus Additives and Their Impact on Phosphorus Content in Foods-An Analysis of the USDAs Branded Foods Product Database

Kelly Picard, Melanie Griffiths, Peter A. Senior, Diana R. Mager, Caroline Richard

Summary: The frequency and impact of phosphate additives in the United States Branded Foods Product Database are unknown. This study found that products with phosphate additives had higher phosphorus content compared to those without additives.

JOURNAL OF RENAL NUTRITION (2023)

Article Cardiac & Cardiovascular Systems

The impact of protein source on serum potassium and phosphate levels in adults living with advanced kidney disease

Kelly Picard, Melanie Griffiths, Janelle Dusterhoft, Shonagh Colebrook-Fonseca, Peter A. Senior, Diana R. Mager, Caroline Richard

Summary: This study aimed to investigate the impact of plant protein intake on serum potassium and phosphate levels in patients with chronic kidney disease. The results showed that increased proportion of plant protein intake was not associated with higher levels of serum potassium or phosphate, but was related to higher fiber intake and diet quality.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2023)

Article Clinical Neurology

Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies

Colin M. Dayan, Beatriz Lecumberri, Ilaria Muller, Sashiananthan Ganesananthan, Samuel F. Hunter, Krzysztof W. Selmaj, Hans-Peter Hartung, Eva K. Havrdova, Christopher C. LaGanke, Tjalf Ziemssen, Bart Van Wijmeersch, Sven G. Meuth, David H. Margolin, Elizabeth M. Poole, Darren P. Baker, Peter A. Senior

Summary: This study aimed to describe the endocrine and multiple sclerosis outcomes over 6 years for alemtuzumab-treated relapsing multiple sclerosis patients. The results showed that the common adverse event of this treatment was autoimmune thyroid events, but it did not affect the disease course.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2023)

Article Endocrinology & Metabolism

Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry

Mikael Chetboun, Elodie Drumez, Cassandra Ballou, Mehdi Maanaoui, Elizabeth Payne, Franca Barton, Julie Kerr-Conte, Marie-Christine Vantyghem, Lorenzo Piemonti, Michael R. Rickels, Julien Labreuche, Francois Pattou

Summary: This global multicentre study shows a linear and independent association between primary graft function (PGF) and 5-year clinical outcomes of islet transplantation. The study reveals that PGF is closely related to the success rate of islet transplantation, graft exhaustion, inadequate glucose control, and the need for exogenous insulin therapy. It emphasizes the importance of PGF in long-term outcomes of islet transplantation.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Article Medicine, Research & Experimental

A normative microbiome is not restored following kidney transplantation

Hannah Craven, Helen Erlandsson, Dagmara Mcguinness, David H. Mcguinness, Denise Mafra, Umer Zeeshan Ijaz, Peter Bergman, Paul G. Shiels, Peter Stenvinkel

Summary: This study investigated the bacterial DNA signatures in the circulation of CKD patients and those receiving KTx treatment. The results suggest that dysbiosis increases as CKD progresses, accompanied by an increase in trimethylamine (TMA) producing pathobionts Pseudomonas and Bacillus. Surprisingly, KTx patients displayed a significantly different microbiota compared to CKD5 patients, with further increase in TMA producing Bacillus and loss of salutogenic Lactobacilli. Two genera (Veillonella and Saccharimonidales) showed significant differences in abundance following KTx, reflecting a reciprocal relationship between TMA producers and utilisers.

CLINICAL SCIENCE (2023)

Article Endocrinology & Metabolism

A glycosylated hemoglobin A1c above 6% (42 mmol/mol) is associated with a high risk of developing Cystic Fibrosis-Related Diabetes and a lower probability of weight gain in both adults and children with Cystic Fibrosis

Kathryn J. Potter, Florence Racine, Anne Bonhoure, Valerie Boudreau, Noemie Belanger, Adele Coriati, Azadeh Shohoudi, Annick Lavoie, Peter A. Senior, Genevieve Mailhot, Remi Rabasa-Lhoret

Summary: The study aimed to identify specific thresholds of glycated hemoglobin A1c associated with the risk of cystic fibrosis-related diabetes (CFRD) progression and changes in body mass index and forced expiratory volume. The results showed that an A1C above 6% may be associated with a high risk of developing CFRD and a lower probability of weight gain in both adults and children with CF.

DIABETES & METABOLISM (2023)

Article Endocrinology & Metabolism

Impact of a modified screening approach during the COVID-19 pandemic on the diagnosis and outcomes of gestational diabetes mellitus: A population-level analysis of 90,518 pregnant women

Vichy Liyanage, Olesya Barrett, Deliwe Ngwezi, Anamaria Savu, Peter Senior, Roseanne O. Yeung, Sonia Butalia, Padma Kaul

Summary: This study aims to provide real-world evidence on the uptake of and outcomes associated with the modified GDM screening approach offered during the COVID-19 pandemic compared with the standard screening approach.

DIABETIC MEDICINE (2023)

Review Endocrinology & Metabolism

Quantifying beta cell function in the preclinical stages of type 1 diabetes

Alfonso Galderisi, Alice L. J. Carr, Mariangela Martino, Peter Taylor, Peter Senior, Colin Dayan

Summary: Clinically symptomatic type 1 diabetes is preceded by a pre-symptomatic phase, during which there is a progressive loss of functional beta cell mass and potential changes in glucose profile. Identifying metabolic tests to track beta cell function is crucial for understanding disease progression and treatment effectiveness.

DIABETOLOGIA (2023)

Meeting Abstract Immunology

Beta-cell function and insulin sensitivity with islet transplant alone and islet-after-kidney transplantation for type 1 diabetes in the Clinical Islet Transplantation (CIT) Consortium

Michael Rickels, Thomas L. Eggerman, Levent Bayman, Julie C. Qidwai, Joseph R. Naji, Huong-Lan Nguyen, Rodolfo Alejandro, Melena D. Bellin, Peter A. Senior, Lawrence G. Hunsicker

TRANSPLANTATION (2023)

Meeting Abstract Immunology

BETA-2 scores overestimate graft function in pancreatic islet transplant recipients with an estimated glomerular filtration rate of <30 ml/min/1.73m2

Braulio Marfil-Garza, Alice L. J. Carr, Meiying Zhuang, Anna Lam, Khaled Dajani, Blaire Anderson, Doug O'Gorman, Tatsuya Kin, David Bigam, James Shapiro, Peter A. Senior

TRANSPLANTATION (2023)

Meeting Abstract Immunology

Analysis of collagenase dose on allogeneic islet isolation outcomes and glucose-stimulated insulin release

Doug O'Gorman, Tatsuya Kin, Shawn Rosichuk, Wendy Zhai, Jennifer Moriarty, Kyle Park, Advaita Ganguly, Peter A. Senior, James A. M. Shapiro

TRANSPLANTATION (2023)

No Data Available